David Klonoff to Hypoglycemic Agents
This is a "connection" page, showing publications David Klonoff has written about Hypoglycemic Agents.
Connection Strength
1.367
-
A randomized, multicentre trial evaluating the efficacy and safety of fast-acting insulin aspart in continuous subcutaneous insulin infusion in adults with type 1 diabetes (onset 5). Diabetes Obes Metab. 2019 04; 21(4):961-967.
Score: 0.302
-
Smart Pens Will Improve Insulin Therapy. J Diabetes Sci Technol. 2018 05; 12(3):551-553.
Score: 0.283
-
A Simplified Approach Using Rate of Change Arrows to Adjust Insulin With Real-Time Continuous Glucose Monitoring. J Diabetes Sci Technol. 2017 11; 11(6):1063-1069.
Score: 0.275
-
Hypoglycemia evaluation and reporting in diabetes: Importance for the development of new therapies. Diabetes Metab Res Rev. 2017 07; 33(5).
Score: 0.266
-
Consensus Statement on Use of Continuous Subcutaneous Insulin Infusion Therapy in the Hospital. J Diabetes Sci Technol. 2018 07; 12(4):880-889.
Score: 0.072
-
Continuous glucose monitoring: A review of the technology and clinical use. Diabetes Res Clin Pract. 2017 Nov; 133:178-192.
Score: 0.069
-
Insulin Pump Occlusions: For Patients Who Have Been Around the (Infusion) Block. J Diabetes Sci Technol. 2017 05; 11(3):451-454.
Score: 0.067
-
Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: an interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled trials. Clin Ther. 2007 Jan; 29(1):139-53.
Score: 0.033